OLD National Bancorp IN decreased its position in Thermo Fisher Scientific Inc (NYSE:TMO) by 19.8% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 114,455 shares of the company’s stock after selling 28,316 shares during the period. Thermo Fisher Scientific comprises about 1.0% of OLD National Bancorp IN’s portfolio, making the stock its 24th largest position. OLD National Bancorp IN’s holdings in Thermo Fisher Scientific were worth $18,205,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also bought and sold shares of the company. Tesco Pension Investment Ltd acquired a new position in Thermo Fisher Scientific during the third quarter worth $137,726,000. FMR LLC raised its position in Thermo Fisher Scientific by 11.3% in the second quarter. FMR LLC now owns 8,216,645 shares of the company’s stock worth $1,214,093,000 after buying an additional 834,858 shares during the last quarter. Carmignac Gestion raised its position in Thermo Fisher Scientific by 23.3% in the second quarter. Carmignac Gestion now owns 4,046,550 shares of the company’s stock worth $597,918,000 after buying an additional 763,421 shares during the last quarter. Standard Life Investments LTD raised its position in Thermo Fisher Scientific by 618.3% in the third quarter. Standard Life Investments LTD now owns 798,124 shares of the company’s stock worth $126,938,000 after buying an additional 687,018 shares during the last quarter. Finally, Janus Capital Management LLC raised its position in Thermo Fisher Scientific by 50.5% in the second quarter. Janus Capital Management LLC now owns 1,972,203 shares of the company’s stock worth $291,410,000 after buying an additional 661,475 shares during the last quarter. 87.29% of the stock is currently owned by institutional investors and hedge funds.
Thermo Fisher Scientific Inc (NYSE:TMO) opened at 140.98 on Wednesday. The firm has a 50-day moving average price of $143.75 and a 200 day moving average price of $150.22. The company has a market capitalization of $55.69 billion, a P/E ratio of 28.18 and a beta of 1.17. Thermo Fisher Scientific Inc has a 52-week low of $119.75 and a 52-week high of $160.68.
Thermo Fisher Scientific (NYSE:TMO) last announced its quarterly earnings results on Thursday, October 27th. The company reported $2.03 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.97 by $0.06. The company earned $4.49 billion during the quarter, compared to analysts’ expectations of $4.39 billion. Thermo Fisher Scientific had a return on equity of 14.95% and a net margin of 11.10%. The firm’s quarterly revenue was up 8.9% compared to the same quarter last year. During the same period in the previous year, the business earned $1.80 earnings per share. On average, analysts predict that Thermo Fisher Scientific Inc will post $8.24 earnings per share for the current fiscal year.
The business also recently declared a quarterly dividend, which was paid on Monday, January 16th. Stockholders of record on Thursday, December 15th were given a $0.15 dividend. This represents a $0.60 annualized dividend and a dividend yield of 0.43%. The ex-dividend date was Tuesday, December 13th. Thermo Fisher Scientific’s dividend payout ratio (DPR) is presently 12.00%.
A number of research analysts have commented on TMO shares. Leerink Swann reaffirmed a “buy” rating and issued a $175.00 price objective on shares of Thermo Fisher Scientific in a report on Sunday, November 20th. Zacks Investment Research lowered Thermo Fisher Scientific from a “buy” rating to a “hold” rating in a report on Wednesday, December 14th. Bank of America Corporation set a $180.00 price objective on Thermo Fisher Scientific and gave the company a “buy” rating in a report on Friday, October 7th. Jefferies Group LLC decreased their price objective on Thermo Fisher Scientific from $163.00 to $160.00 and set a “hold” rating on the stock in a report on Monday. Finally, Goldman Sachs Group, Inc. (The) reaffirmed a “conviction-buy” rating and issued a $168.00 price objective (down from $170.00) on shares of Thermo Fisher Scientific in a report on Monday, December 12th. Three research analysts have rated the stock with a hold rating, thirteen have given a buy rating and one has issued a strong buy rating to the company’s stock. Thermo Fisher Scientific presently has a consensus rating of “Buy” and a consensus target price of $165.58.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company is a provider of analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. The company operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.
Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc (NYSE:TMO).